Results 81 to 90 of about 5,248,297 (184)

Doença de células de langerhans e mama.

Acta Médica Portuguesa, 2011
Langerhans cell histiocytosis (LCH) is a rare systemic disorder, with a diversified presentation and natural history. It can compromise any organ. We report a case of a 32-year-old woman who came to our clinic with an asymptomatic palpable breast mass ...
Cátia Rodrigues, Paulo Santos, Dora Simões, Maria Odete Valério, C Calhaz-Jorge   +4 more
doaj   +1 more source

Disseminated Mixed Lytic‐Sclerotic Skeletal Metastases as Initial Presentation of Gallbladder Carcinoma: A Case Report

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Gallbladder carcinoma is an aggressive malignancy often diagnosed at an advanced stage. Skeletal metastasis, especially mixed lytic‐sclerotic lesions, is rare and typically occurs late. This report highlights an unusual presentation where widespread bony metastases were the initial manifestation, leading to the diagnosis of gallbladder ...
Shivali Rao, Binaya Adhikari, Abhikanta Khatiwada   +2 more
wiley   +1 more source

Epidural spinal cord compression in Langerhans cell histiocytosis: A case report

, 2013
Langerhans cell histiocytosis, also known as histiocytosis X, is a rare proliferative disorder of histiocytes. Spinal involvement in the course of Langerhans cell histiocytosis in adult is rare, and epidural location is exceptional.
MONTEMURRO, NICOLA, PERRINI, PAOLO, Vannozzi, Riccardo   +2 more
core   +1 more source

A large multilobulated cutaneous nodule in infancy

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Hannah Wahida, Andy Yan, Stephan Forchhammer   +2 more
wiley   +1 more source

Behavior Change Interventions to Promote Healthy Lifestyles Among Adolescent and Young Adult Childhood Cancer Survivors: A Scoping Review

Cancer Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background Adolescent and young adult childhood cancer survivors (AYA‐CCS) face elevated risks of chronic health conditions and premature mortality further exacerbated by poor lifestyle behaviors including physical inactivity, poor nutrition, and substance use.
C. Gélinas‐Gagné, K. Bilodeau, N. Guarascio, M. Caru, H. Coltin, D. Curnier, L. Desjardins, C. Laverdière, V. Marcil, R. Santiago, S. Vairy, S. Sultan   +11 more
wiley   +1 more source

Cutaneous Langerhans Cell Histiocytosis

, 2008
We report a 4-year-old boy with localized Langerhans cell histiocytosis. The lesions were restricted to the skin of his back, eyelids, glans penis and prepuce for 2 years. Histopathological and electron microscopic examinations showed typical features of
吳亮遠;蔡呈芳;陳佑甫;洪志明, WU, LIANG-YUANNG;TSAI, TSEN-FANG;CHEN, YU-FU;HUNG, CHIN-MING;WU, CHIEH-JEN   +1 more
core  

MEK inhibition achieves robust and durable responses in Erdheim–Chester disease

HemaSphere, Volume 10, Issue 10, October 2026.
Abstract Erdheim–Chester disease (ECD) is a rare histiocytic neoplasm characterized by heterogeneous clinical manifestations and limited evidence to guide targeted therapy. While MEK inhibitors (MEKi) are increasingly used, data on their real‐world efficacy, durability, and safety remain incomplete.
Francesco Pegoraro, Félicien Triboulet, Matthias Papo, Francesco Peyronel, Anita Argentieri, Jerome Razanamahery, Ahmed Idbaih, Polyzois Makras, Ofer Shpilberg, Oshrat Hershkovitz‐Rokah, Michael Girschikofsky, Matthew Collin, Kristian Bowles, Satyen H. Gohil, Rodothea Amerikanou, Emmanuel Ledoult, Tanguy Le Scornet, Mathilde de Menthon, Etienne Riviere, Xavier Boulu, Henry Dupuy, Achille Aouba, Stanislas Faguer, Xavier Solanich, Elena Sieni, Stéphane Barete, Chiara Bellino, Alessandro Tomelleri, Corrado Campochiaro, Lorenzo Dagna, Zahir Amoura, Jean‐François Emile, Fleur Cohen‐Aubart, Augusto Vaglio, Julien Haroche   +34 more
wiley   +1 more source

Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis.

, 2016
Langerhans cell histiocytosis (LCH) is characterized by inflammatory lesions containing pathologic ...
Abhyankar, Harshal, MS, McClain, Kenneth L, Poulikakos, Poulikos I, Kakkar, Nipun, Zinn, Daniel J, MD, Parsons, D Williams, Chakraborty, Rikhia, PhD, Lim, Karen Phaik Har, MS, Hampton, Oliver A, Scull, Brooks, MS, Wheeler, David A, Kumar, Vijetha, Allen, Carl E, MD, PhD, Burke, Thomas M, BS, Roy, Angshumoy, Merad, Miriam, MD, PhD   +15 more
core   +1 more source

Adult‐Onset Central Nervous System Erdheim–Chester Disease Successfully Treated With Cladribine and Cytarabine: Case Report and Literature Review

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Erdheim–Chester disease (ECD) is a rare histiocytic disorder with heterogeneous clinical manifestations. Central nervous system (CNS) involvement is associated with poor prognosis. Although targeted therapies have improved outcomes in patients with mitogen‐activated protein kinase (MAPK) pathway alterations, optimal treatment strategies for ...
Naoki Watanabe, Hajime Yasuda, Midori Ishii, Norihide Izumi, Ayaka Goto, Tadaaki Inano, Yuji Tomizawa, Taku Hatano, Miki Ando   +8 more
wiley   +1 more source

LANGERHANS CELL HISTIOCYTOSIS

, 2005
Ulcerated nodules are often seen in the flexural areas of patients with Langerhans cell histiocytosis, or histiocytosis X (2,5-7). Infants with this condition have widespread cutaneous disease with a seborrheic rash involving the scalp and flexural ...

core   +1 more source